Abstract:Sinonasal mucosal melanomas (SNMM) of the head and neck regions are rare and aggressive malignancies. Although they can affect patients of any ethnicity, they are more numerous in Chinese patients. The diagnosis and treatment of these tumors can be challenging. Recent studies have reported that Sox10 is a sensitive melanocytic marker for cutaneous melanoma (Nonaka et al. in Am J Surg Pathol 32:1291–1298, 2008). In addition, a CD117 (c-kit) gene mutation has been identified in cutaneous melanomas, indicating that there may be potential therapeutic benefits of tyrosine kinase inhibitors, such as Imatinib. The purpose of this study was to detect and test the immunohistochemical expression of Sox10 and c-kit in mucosal melanomas (MM) arising in the nasal cavities of Chinese patients. Twenty eight patients with mucosal melanomas of the nasal cavity were treated in two major hospitals in China. All cases had been locally diagnosed as primary SNMM. We confirmed all diagnoses with positive immunohistochemical stains for S100 and HMB-45. Additionally, automated immunohistochemistry was performed using a goat polyclonal Sox10 antibody and a monoclonal c-kit antibody counterstained using a standard avidin–biotin complex method. Immunohistochemical positive expression of Sox10 was defined by nuclear stain; and positivity for c-kit resulted in a distinct membranous staining. The extent of nuclear positivity for Sox10 and membranous stain for c-kit was graded by 4 board certified pathologists as follows: 1+, 1–25 % of positive tumor cells; 2+, 25–50 %; 3+, 50–75 %; and 4+, ≥75 %. Sox10 nuclear expression was found in all cases (100 %), with 4+ staining in 26 out of 28 cases (92.8 %) and 3+ staining in two cases with (7.1 %). The overall positivity for S100 staining was 23 out of 28 (82.1 %), with 1+ staining in 10 cases, 2+ staining in 6 cases, 3+ staining in 7 cases, and no staining in 5 cases. The sensitivity and intensity of Sox10 immunohistochemistry were both higher than with S100 immunohistochemistry. Immunopositivity of membranous stain for c-kit (CD117) was seen in 24 out of 28 cases (85.7 %), including 6 tumors that were 4+, eight that were 3+, six that were 2+, and four that showed 1+ staining. Our results demonstrate that Sox10 is a sensitive marker for SNMM and it may possess diagnostic value in addition to that of S100 protein. The expression of c-kit in the majority of MMs suggests that it may be useful in the assessment of these tumors for potential treatment with tyrosine kinase inhibitors.

SOX11, SOX10 and MITF Gene Interaction: A Possible Diagnostic Tool in Malignant Melanoma

Stage-specific prognostic biomarkers in melanoma.

Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi

HMB-45 May Be a More Sensitive Maker Than S-100 or Melan-A for Immunohistochemical Diagnosis of Primary Oral and Nasal Mucosal Melanomas.

Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas

Expression of Sox10 and C-Kit in Sinonasal Mucosal Melanomas Arising in the Chinese Population

Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions

Identification of an m6A Regulators-Mediated Prognosis Signature For Survival Prediction and Its Relevance to Immune Infiltration in Melanoma

New panel of biomarkers to discriminate between amelanotic and melanotic metastatic melanoma

Quadruple Negative Metastatic Melanoma With Gain of SOX-11 Expression and TERT Mutation

Mitf-Mdel, a Novel Melanocyte/melanoma-Specific Isoform of Microphthalmia-Associated Transcription Factor-M, As a Candidate Biomarker for Melanoma

Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67

Identification, Validation, And Functional Annotations Of Genome-Wide Profile Variation Between Melanocytic Nevus And Malignant Melanoma

Proliferation Marker Ki67 As a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma.

Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma

Evaluation of SOX-10 immunohistochemical expression in canine melanoma and non-melanocytic tumors by tissue microarray

The association of Ki67 level and adjuvant treatment options in mucosal melanoma.

Evaluation of tubulin β-3 and 5 hydroxy-methyl cytosine as diagnostic and prognostic markers in malignant melanoma

Characterizing CD133 and NANOG Expression in Melanoma: Associations with Histological and Epidemiological Parameters

[Expression of Neutral Endopeptidase and Motility-Related Protein-1 in Cutaneous Malignant Melanoma].

Integrative Analysis of Minichromosome Maintenance Proteins and Their Prognostic Significance in Melanoma